FDA Approves Pfizer's New Pneumococcal Vaccine, Setting Up Clash With Merck

Retrieved on: 2021-06-09 12:33:45

Tags for this article:

Vaccination

Medical specialties

Health care

Vaccines

Pneumococcal conjugate vaccine

Pneumococcal polysaccharide vaccine

Advisory Committee on Immunization Practices

Click the tags to see associated articles and topics

FDA Approves Pfizer's New Pneumococcal Vaccine, Setting Up Clash With Merck. View article details on hiswai:

Excerpt

Pfizer sold $5.8 billion worth of Prevnar 13 in 2020 and dominates the market, while sales of Merck's (MRK) product, Pneumovax 23, totaled just $1.1 ...

Article found on: www.barrons.com

View Original Article